I
ImmunoGen Inc
XETRA:IMU
ImmunoGen Inc
XETRA:IMU
Price:
8.58
EUR
Market Closed
Market Cap:
€1.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
I
|
ImmunoGen Inc
XETRA:IMU
|
US |
|
M
|
Maybank Securities Thailand PCL
SET:MST
|
TH |
|
H
|
Hutter & Schrantz Stahlbau AG
VSE:HST
|
AT |
|
IHS Holding Ltd
NYSE:IHS
|
UK |
|
P
|
Payton Industries Ltd
TASE:PAYT
|
IL |
|
nCino OpCo, Inc.
NASDAQ:NCNO
|
US |
|
J
|
Josef Manner & Comp AG
VSE:MAN
|
AT |
|
W
|
WHA Premium Growth Freehold and Leasehold Real Estate Investment Trust
SET:WHART
|
TH |
|
C
|
Ceridian HCM Holding Inc
TSX:CDAY
|
US |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is IMU's stock price target?
Not Available
IMU doesn't have any price targets made by Wall Street professionals.
What is ImmunoGen Inc's Revenue forecast?
Projected CAGR
75%
75%
For the last 9 years the compound annual growth rate for ImmunoGen Inc's revenue is 7%. The projected CAGR for the next 4 years is 75%.
